Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population

Journal of Medical Virology

Volumn 83, Issue 5, 2011, Pages 833-837

  Ili, Carmen G ^a   Brebi, Priscilla ^a   López, Jaime ^a   García, Patricia ^a   Leal, Pamela ^a   Suarez, Eugenio ^b   Roa, Juan C ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Polymerase chain reaction reverse line blotting assay

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MOLECULAR HYBRIDIZATION; NONHUMAN; PAPILLOMAVIRUS INFECTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILE; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR TYPING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79952730822     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22057     Document Type: Article

References (23)

1. Aedo S, Melo A, García P, Guzmán P, Capurro I, Roa JC. 2007. Detección y tipificación de virus papilloma humano en lesiones preneoplásicas del cuello uterino mediante PCR-RFLP. Rev Med Chil 135: 167-173.
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802.
3. Burd EM. 2003. Human papillomavirus and cervical cancer. Clin Microbiol Rev 16: 1-17.
4. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89: 101-105.
5. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88: 63-73.
6. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S. 2005a. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366: 991-998.
7. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005b. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14: 1157-1164.
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
9. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. 2004. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13: 2271-2276.
10. Huang SL, Chao A, Hsueh S, Chao FY, Huang CC, Yang JE, Lin CY, Yan CC, Chou HH, Huang KG, Huang HJ, Wu TI, Tseng MJ, Qiu JT, Lin CT, Chang TC, Lai CH. 2006. Comparison between the hybrid capture II test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples. J Clin Microbiol 44: 1733-1739.
11. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity, and frequency of referral. JAMA 288: 1749-1757.
12. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. 2006. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst 98: 92-100.
13. Lai HC, Peng MY, Nieh S, Yu CP, Chang CC, Lin YW, Sun CA, Chu TY. 2006. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis. Int J Gynecol Cancer 16: 730-735.
14. Melo A, Montenegro S, Hooper T, Capurro I, Roa JC, Roa I. 2003. Human papilloma virus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX region-Chile. Rev Med Chil 131: 1382-1390.
15. Melo A, Roa I, Montenegro S, Capurro I, Roa JC. 2005. Detection of human papilloma virus in cytologic samples or biopsies of the cervix. Rev Med Chil 133: 639-644.
16. Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T. 2004. The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J Med Sci 50: 9-19.
17. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
18. Roa JC, Garcia P, Gomez J, Fernandez W, Gaete F, Espinoza A, Lepetic A, Suarez E. 2009. HPV genotyping from invasive cervical cancer in Chile. Int J Gynaecol Obstet 105: 150-153.
19. Valdivia LI, Aguayo GF, Pruyas AM, Snijders PJ, Corvalan RA, Ferreccio RC. 2010. Human papillomavirus (HPV) genotypes in cervix uterine cancer patients in a public hospital and private clinic from Santiago, Chile. Rev Chilena Infectol 27: 11-16.
20. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779-787.
21. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
22. WHO/ICO. 2010. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Americas. Summary Report 2010. [September 15, 2010]. Available at
23. Woodman C, Collins SI, Young LS. 2007. The natural history of cervical HPV infection: Unresolved issues. Nat Rev Cancer 7: 11-22.